VELETRI: payments to doctors
Payments that named VELETRI as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $143K
- Providers
- 115
- Transactions
- 342
- Average per transaction
- $418
The per-transaction average — $418 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 115 providers the average total is $1,242, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Johnson & Johnson | $140,831 | 98.6% |
| Actelion Pharmaceuticals US, Inc. | $1,994 | 1.4% |